Discussion regarding options for treatment of recurrent cervical clear cell carcinoma included traditional systemic chemotherapy regimens as well as consideration of previous tumor genomics result that demonstrated a somatic BRCA2 mutation. The gene discussed is BRCA2; the disease is neoplasm.